Cwm LLC Raises Stock Position in CVS Health Corporation $CVS

Cwm LLC lifted its stake in CVS Health Corporation (NYSE:CVS) by 81.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 144,332 shares of the pharmacy operator’s stock after buying an additional 64,963 shares during the period. Cwm LLC’s holdings in CVS Health were worth $10,881,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. grew its holdings in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Avion Wealth grew its stake in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new position in CVS Health during the second quarter worth approximately $30,000. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Finally, Front Row Advisors LLC boosted its holdings in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.6%

NYSE CVS opened at $79.60 on Monday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $101.04 billion, a P/E ratio of 209.47, a P/E/G ratio of 0.79 and a beta of 0.48. CVS Health Corporation has a 52-week low of $43.65 and a 52-week high of $85.15. The firm has a 50-day moving average price of $78.91 and a 200 day moving average price of $73.02.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent research reports. Piper Sandler reaffirmed an “overweight” rating and issued a $101.00 target price (up from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Wells Fargo & Company dropped their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 22nd. Morgan Stanley raised their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Finally, Raymond James Financial upped their price objective on CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.